Ye Huijun, Yang Yi, Zhu Ping, Zheng Huiling, Lin Yunxia, Liu Jiali, Li Ruilan, Jin Lihua
Department of Gynaecology and Obstetrics, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Radiology Department, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Medicine (Baltimore). 2025 May 9;104(19):e42327. doi: 10.1097/MD.0000000000042327.
Pregnant and postpartum women have a hypercoagulable state, and COVID-19 infection further heightens the risk of venous thromboembolism, with pulmonary embolism (PE) in COVID-19-infected pregnant women being a global concern.
A 47-year-old pregnant woman with a history of 3 vaginal deliveries and 1 cesarean section, who had a neo-coronavirus infection 29 days ago with rapid symptom resolution, developed asymptomatic massive PE within 24 hours after cesarean section at 38+ weeks of gestation.
Massive PE was diagnosed by computed tomography pulmonary angiography, which showed thromboembolism in multiple parts of the pulmonary arteries, along with pleural effusion and lung inflammation. Cardiac ultrasound revealed mildly elevated pulmonary artery systolic pressure and mild mitral and tricuspid regurgitation.
Anticoagulation therapy was initially with enoxaparin sodium injection, and the dosage was adjusted. Intravenous anti-infection therapy was also given. After discharge, the patient was switched to rivaroxaban. Compression stockings were used for venous thromboembolism prevention.
After 5 months of anticoagulation therapy, the computed tomography pulmonary angiography of the pulmonary artery was completely normalized, but a small amount of interstitial lung lesions still persisted.
Pregnant women infected with the new coronavirus need close attention during pregnancy and puerperium, especially those with thrombosis risk factors who should receive early anticoagulation. There are many aspects worthy of further exploration, such as the necessity of early pulmonary computed tomography scans and appropriate anticoagulant dosage in pregnant women with COVID-19 infection.
孕妇和产后女性处于高凝状态,而新型冠状病毒肺炎(COVID-19)感染会进一步增加静脉血栓栓塞的风险,COVID-19感染孕妇的肺栓塞(PE)是全球关注的问题。
一名47岁孕妇,有3次阴道分娩和1次剖宫产史,29天前感染新型冠状病毒且症状迅速缓解,在孕38 +周剖宫产术后24小时内发生无症状大面积PE。
通过计算机断层扫描肺动脉造影诊断为大面积PE,显示肺动脉多个部位有血栓栓塞,伴有胸腔积液和肺部炎症。心脏超声显示肺动脉收缩压轻度升高,二尖瓣和三尖瓣轻度反流。
抗凝治疗最初使用低分子肝素钠注射液,并调整剂量。还给予了静脉抗感染治疗。出院后,患者改用利伐沙班。使用弹力袜预防静脉血栓栓塞。
经过5个月的抗凝治疗,肺动脉计算机断层扫描肺动脉造影完全恢复正常,但仍有少量间质性肺病变。
感染新型冠状病毒的孕妇在孕期和产褥期需要密切关注,尤其是有血栓形成危险因素的孕妇应尽早接受抗凝治疗。还有许多方面值得进一步探索,如COVID-19感染孕妇早期肺部计算机断层扫描的必要性和合适的抗凝剂量。